Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of single-use medical devices. The Company operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.

Employees

12,719

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-26 - Q2 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
25-06-20	6.000 $	+2.56%	9,841,620
25-06-19	5.850 $	-2.50%	6,941,781
25-06-18	6.000 $	-2.28%	6,763,684
25-06-17	6.140 $	-0.49%	15,079,990
25-06-16	6.170 $	+1.82%	24,720,020

Delayed Quote Hong Kong S.E., June 20, 2025 at 04:08 am

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.487CNY

Average target price

6.213CNY

Spread / Average Target

+13.23%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2025-06-20 EDT			5-day change	1st Jan Change
6.000 ^HKD	+2.56%		-0.99%	+30.43%

05-28	Shandong Weigao's Vice-Chairman Steps Down; Successor Named	MT
05-28	Shandong Weigao Group Medical Polymer Company Limited Announces Change of Vice Chairman, Effective 28 May 2025	CI

Capitalization	25.04B 27.38B 3.49B 3.03B 2.85B 2.59B 4.79B 302B 5.4B 33.74B 12.91B 138B 13.09B 12.81B 509B	P/E ratio 2025 *	10.9x	P/E ratio 2026 *	10.1x
Enterprise value	19.06B 20.85B 2.66B 2.3B 2.17B 1.97B 3.65B 230B 4.11B 25.69B 9.83B 105B 9.96B 9.75B 387B	EV / Sales 2025 *	1.33x	EV / Sales 2026 *	1.19x
Free-Float	53%	Yield 2025 *	4.55%	Yield 2026 *	5%

Shandong Weigao's Vice-Chairman Steps Down; Successor Named	05-28	MT
Shandong Weigao Group Medical Polymer Company Limited Announces Change of Vice Chairman, Effective 28 May 2025	05-28	CI
Shandong Weigao Group Medical Polymer Company Limited commences an Equity Buyback Plan for 451,560,392 shares, representing 9.89% of its issued share capital, under the authorization approved on May 27, 2025.	05-27	CI
Shandong Weigao Group Medical Polymer Company Limited's Equity Buyback announced on February 11, 2025, has expired.	05-26	CI
Shandong Weigao Blood Purification Products Co., Ltd. announced that it expects to receive CNY 170 million in funding from Shandong Weigao Group Medical Polymer Company Limited	05-26	CI
Weigao Group Medical Polymer Buys Back Shares Worth HK$1.6 Million	05-22	MT
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	03-26	CI
Shandong Weigao Group Medical Polymer Repurchases Shares Worth HK$5 Million	02-21	MT
Shandong Weigao Group Medical Polymer Repurchase 50,000 Shares	02-12	MT
Shandong Weigao Group Medical Polymer Company Limited commences an Equity Buyback Plan for 452,233,232 shares, representing 10% of its issued share capital, under the authorization approved on May 28, 2024.	02-11	CI
Shandong Weigao Group Medical Polymer Company Limited and Weigao International Holding Corporation Pte. Limited Enters into Loan Agreements with International Finance Corporation	12-06	CI
Shandong Weigao Group Medical Polymer Records 8% Lower Profit in H1	24-08-28	MT
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-28	CI

Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$6.29 From HK$8.45, Keeps at Buy	24-07-22	MT
Nomura Adjusts Shandong Weigao Group Medical Polymer’s Price Target to HK$8.45 From HK$9.91, Keeps at Buy	24-03-08	MT
Nomura Adjusts Shandong Weigao's Price Target to HK$13.26 From HK14.79, Keeps at Buy	23-08-01	MT
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy	23-03-31	MT
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$15.90 From HK$13.33, Keeps at Buy	23-02-24	MT

Shandong Weigao Group Medical Polymer Company Limited Stock

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Valuation: Shandong Weigao Group Medical Polymer Company Limited

Chart: Shandong Weigao Group Medical Polymer Company Limited

Latest news: Shandong Weigao Group Medical Polymer Company Limited

Analysts' recommendations: Shandong Weigao Group Medical Polymer Company Limited

Press Releases: Shandong Weigao Group Medical Polymer Company Limited

Quotes and Performance

Course Extremes

Managers and Directors: Shandong Weigao Group Medical Polymer Company Limited

ETFs: Shandong Weigao Group Medical Polymer Company Limited

Medical Supplies

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

Shandong Weigao Medical Polymer : PROXY FORM FOR THE ANNUAL GENERAL MEETING	21-04-26	PU
Shandong Weigao Medical Polymer : (1) GENERAL MANDATES TO ISSUE AND TO REPURCHASE OF H SHARES (2) APPOINTMENT OF DIRECTORS (3) RE-ELECTION OF RETIRING INDEPENDENT NON EXECUTIVE DIRECTORS WHO HAVE SERVED THE COMPANY FOR NINE YEARS (4) PROPOSED AMENDMENT OF THE ARTICLES OF ASSOCIATION (5) PROPOSED FINAL DIVIDEND AND (6) NOTICE OF ANNUAL GENERAL MEETING	21-04-26	PU
Shandong Weigao Medical Polymer : APPOINTMENT AND RESIGNATION OF DIRECTORS, RE-ELECTION OF RETIRING INDEPENDENT NON-EXECUTIVE DIRECTORS WHO HAVE SERVED MORE THAN NINE YEARS AND CHANGE OF CHAIRMAN OF THE BOARD, CHIEF EXECUTIVE OFFICER AND AUTHORISED REPRESENTATIVE	21-03-30	PU
Shandong Weigao Medical Polymer : PROPOSED AMENDMENT OF THE ARTICLES OF ASSOCIATION	21-03-30	PU
Shandong Weigao Medical Polymer : POLL RESULTS FOR THE EXTRAORDINARY GENERAL MEETING HELD ON 8 MARCH 2021	21-03-08	PU

1 day	+2.56%
1 week	-0.99%
Current month	+6.95%
1 month	+0.17%
3 months	+15.38%
6 months	+32.74%
Current year	+30.43%

1 week	5.76	6.37
1 month	5.23	6.37
Current year	4.09	6.37
1 year	3.6	6.54
3 years	3.6	14.36
5 years	3.6	22.7
10 years	3.6	22.7

Manager	Title	Age	Since
Rinan Cong CEO	Chief Executive Officer	44	2021-03-29
Jing Long CEO	Chief Executive Officer	51	2018-07-31
Xue Feng Wu DFI	Director of Finance/CFO	47	2001-06-30

Director	Title	Age	Since
Jing Long CHM	Chairman	51	2021-03-29
Lin Chen BRD	Director/Board Member	50	2021-03-07
Zheng Peng Tang BRD	Director/Board Member	54	2021-03-07

	2025 *	2026 *
Net sales	14.29B 15.62B 1.99B 1.73B 1.63B 1.48B 2.73B 172B 3.08B 19.25B 7.37B 78.96B 7.47B 7.31B 290B	15.45B 16.89B 2.15B 1.87B 1.76B 1.6B 2.96B 186B 3.33B 20.82B 7.97B 85.37B 8.07B 7.9B 314B
Net income	2.29B 2.5B 319M 276M 260M 236M 437M 27.59B 493M 3.08B 1.18B 12.64B 1.2B 1.17B 46.46B	2.49B 2.72B 346M 301M 283M 257M 476M 30.01B 536M 3.35B 1.28B 13.75B 1.3B 1.27B 50.53B
Net Debt	-5.97B -6.53B -832M -722M -680M -618M -1.14B -72.04B -1.29B -8.05B -3.08B -33B -3.12B -3.05B -121B	-6.72B -7.35B -936M -812M -765M -695M -1.29B -81.11B -1.45B -9.06B -3.47B -37.16B -3.51B -3.44B -137B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	+2.56%	-0.99%	+53.85%	-27.54%	3.49B
COLOPLAST A/S	+0.10%	-3.80%	-27.50%	-19.90%	21.32B
WINNER MEDICAL CO., LTD.	-1.94%	-12.52%	+57.62%	-9.36%	3.32B
INTCO MEDICAL TECHNOLOGY CO., LTD.	-0.47%	+1.92%	-10.45%	-3.87%	2.08B
TOP GLOVE CORPORATION BHD.	0.00%	-7.14%	-36.73%	-33.80%	1.35B
HARTALEGA HOLDINGS	-0.63%	-10.23%	-53.80%	-46.26%	1.27B
KANGJI MEDICAL HOLDINGS LIMITED	+1.08%	-2.98%	+30.21%	-1.57%	1.15B
NAKANISHI INC.	+2.15%	-2.84%	-25.35%	-22.31%	1.06B
GVS S.P.A.	+1.64%	+4.03%	-31.89%	-37.36%	1.01B
PAUL HARTMANN AG	-0.40%	+1.23%	+23.00%	-21.15%	1.01B
Average	+0.41%	-3.02%	-2.10%	-22.31%	3.71B
Weighted average by Cap.	+0.21%	-3.64%	-9.39%	-20.19%